ロード中...
Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?
The first generation direct antiviral agents (DAAs) highlighted substantial prognosis improvement among liver transplant (LT) candidates and recipients with recurrent hepatitis C virus (HCV) infection. During 2014, second generation DAAs are associated with high sustained virological response rates...
保存先:
| 出版年: | World J Hepatol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Inc
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4483543/ https://ncbi.nlm.nih.gov/pubmed/26140081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v7.i12.1606 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|